Zai Lab (ZLAB) Change in Cash (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Change in Cash of -$28.3 million for Q1 2026, down 109.19% year-on-year from $307.6 million in Q1 2025, and up 24.81% on a QoQ basis from -$37.6 million in Q4 2025.
Zai Lab (ZLAB) Change in Cash (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Change in Cash for 9 consecutive years, with -$28.3 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 109.19% year-over-year to -$28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$105.9 million (down 199.49% YoY) and the FY2025 annual result came in at $229.9 million, up 195.6% from the prior year.
- Change in Cash climbed to -$28.3 million in Q1 2026 per ZLAB's latest filing, from -$37.6 million in the prior quarter.
- Over the last five years, Change in Cash for ZLAB reached as high as $438.7 million in Q3 2022 and fell as low as -$166.4 million in Q4 2024.
- A 5-year average of -$12.5 million and a median of -$28.3 million in 2026 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash slumped 25088.44% — and 2025, when it soared 881.29%.
- Year by year, Change in Cash stood at -$111.0 million in 2022, then jumped by 100.6% to $666000.0 in 2023, then sank by 25088.44% to -$166.4 million in 2024, then jumped by 77.42% to -$37.6 million in 2025, then advanced by 24.81% to -$28.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$28.3 million, -$37.6 million, and -$15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -28.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.26 Mn |
| Dec 31, 2025 | -37.58 Mn |
| Sep 30, 2025 | -15.11 Mn |
| Jun 30, 2025 | -24.99 Mn |
| Mar 31, 2025 | 307.60 Mn |
| Dec 31, 2024 | -166.42 Mn |
| Sep 30, 2024 | -13.96 Mn |
| Jun 30, 2024 | -20.73 Mn |
| Mar 31, 2024 | -39.37 Mn |
| Dec 31, 2023 | 666,000.00 |
| Sep 30, 2023 | -70.35 Mn |
| Jun 30, 2023 | -19.90 Mn |
| Mar 31, 2023 | -128.43 Mn |
| Dec 31, 2022 | -111.01 Mn |
| Sep 30, 2022 | 438.66 Mn |
| Jun 30, 2022 | -166.14 Mn |
| Mar 31, 2022 | -117.14 Mn |
| Dec 31, 2021 | -434.34 Mn |
| Sep 30, 2021 | -368.08 Mn |
| Jun 30, 2021 | 753.15 Mn |